WKY |
efferent arteriolar resistance |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney blood vessel physiology trait |
male |
0 days
| 8 |
17.0 |
x 10E10 dyne x s/cm5 |
1.0 |
2.83 |
p-aminohippurate analysis by liquid phase colorimetry |
renal efferent arteriole |
0.0 |
|
0 |
|
pe |
100544 |
2479 |
WKY |
efferent arteriolar resistance |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney blood vessel physiology trait |
male |
0 days
| 9 |
22.0 |
x 10E10 dyne x s/cm5 |
1.0 |
3.0 |
p-aminohippurate analysis by liquid phase colorimetry |
renal efferent arteriole |
0.0 |
PA IV 50mg/kg |
0 |
|
pe |
100545 |
2479 |
WKY |
efferent arteriolar resistance |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney blood vessel physiology trait |
male |
0 days
| 9 |
1.54 |
x 10E10 dyne x s/cm5 |
0.12 |
0.36 |
p-aminohippurate analysis by liquid phase colorimetry |
renal efferent arteriole |
0.0 |
PA IV 50mg/kg |
0 |
|
re |
100560 |
2479 |
WKY |
efferent arteriolar resistance |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney blood vessel physiology trait |
male |
0 days
| 6 |
0.84 |
x 10E10 dyne x s/cm5 |
0.1 |
0.24 |
p-aminohippurate analysis by liquid phase colorimetry |
renal efferent arteriole |
0.0 |
PA IV 50mg/kg |
15 |
days |
re |
100558 |
2479 |
WKY |
efferent arteriolar resistance |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney blood vessel physiology trait |
male |
0 days
| 8 |
0.82 |
x 10E10 dyne x s/cm5 |
0.08 |
0.23 |
p-aminohippurate analysis by liquid phase colorimetry |
renal efferent arteriole |
0.0 |
|
0 |
|
re |
100559 |
2479 |
WKY |
efferent arteriolar resistance |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney blood vessel physiology trait |
male |
0 days
| 8 |
24.0 |
x 10E10 dyne x s/cm5 |
0.4 |
1.13 |
p-aminohippurate analysis by liquid phase colorimetry |
renal efferent arteriole |
0.0 |
PA IV 50mg/kg |
0 |
|
pe |
100546 |
2479 |
WKY |
efferent arteriolar resistance |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney blood vessel physiology trait |
male |
0 days
| 9 |
1.13 |
x 10E10 dyne x s/cm5 |
0.12 |
0.36 |
p-aminohippurate analysis by liquid phase colorimetry |
renal efferent arteriole |
0.0 |
|
0 |
|
re |
100557 |
2479 |
WKY |
efferent arteriolar resistance |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney blood vessel physiology trait |
male |
0 days
| 9 |
18.0 |
x 10E10 dyne x s/cm5 |
1.0 |
3.0 |
p-aminohippurate analysis by liquid phase colorimetry |
renal efferent arteriole |
0.0 |
|
0 |
|
pe |
100542 |
2479 |
WKY |
efferent arteriolar resistance |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney blood vessel physiology trait |
male |
0 days
| 8 |
0.5 |
x 10E10 dyne x s/cm5 |
0.07 |
0.2 |
p-aminohippurate analysis by liquid phase colorimetry |
renal efferent arteriole |
0.0 |
PA IV 50mg/kg |
0 |
|
re |
100561 |
2479 |
WKY |
efferent arteriolar resistance |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney blood vessel physiology trait |
male |
0 days
| 6 |
21.0 |
x 10E10 dyne x s/cm5 |
1.0 |
2.45 |
p-aminohippurate analysis by liquid phase colorimetry |
renal efferent arteriole |
0.0 |
PA IV 50mg/kg |
15 |
days |
pe |
100543 |
2479 |